• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials.

作者信息

Martinez-Garcia Miguel Angel, Posadas Tomás, Sotgiu Giovanni, Blasi Francesco, Saderi Laura, Aliberti Stefano

机构信息

Pneumology Department, Hospital Universitario i Politécnico La Fe, Valencia, Spain.

Pneumology Department, Hospital Universitario i Politécnico La Fe, Valencia, Spain.

出版信息

Respir Med. 2020 Oct;172:106127. doi: 10.1016/j.rmed.2020.106127. Epub 2020 Aug 25.

DOI:10.1016/j.rmed.2020.106127
PMID:32905889
Abstract
摘要

相似文献

1
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials.吸入性糖皮质激素在降低合并血液嗜酸性粒细胞增多的支气管扩张症患者急性加重发作中的作用：两项随机临床试验的事后汇总分析
Respir Med. 2020 Oct;172:106127. doi: 10.1016/j.rmed.2020.106127. Epub 2020 Aug 25.
2
Inhaled steroids for bronchiectasis.用于支气管扩张症的吸入性类固醇。
Cochrane Database Syst Rev. 2009 Jan 21(1):CD000996. doi: 10.1002/14651858.CD000996.pub2.
3
Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis.血液嗜酸性粒细胞计数，在后 RCT 和观察性研究中预测吸入性皮质类固醇预防 COPD 加重的有效性标志物：系统评价和荟萃分析。
Respir Res. 2020 Jan 3;21(1):3. doi: 10.1186/s12931-019-1268-7.
4
Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).临床实践研究数据库（CPRD）中的血嗜酸性粒细胞计数、吸入性皮质类固醇的停用与 COPD 加重和死亡率的关系。
COPD. 2019 Apr;16(2):152-159. doi: 10.1080/15412555.2019.1608172. Epub 2019 May 23.
5
Efficacy of inhaled ciprofloxacin agents for the treatment of bronchiectasis: a systematic review and meta-analysis of randomized controlled trials.吸入环丙沙星类药物治疗支气管扩张症的疗效：系统评价和随机对照试验的荟萃分析。
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619875930. doi: 10.1177/1753466619875930.
6
Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.血嗜酸性粒细胞计数与慢性阻塞性肺疾病患者肺炎风险：一项基于患者的荟萃分析。
Lancet Respir Med. 2016 Sep;4(9):731-741. doi: 10.1016/S2213-2600(16)30148-5. Epub 2016 Jul 23.
7
Absolute Blood Eosinophil Counts to Guide Inhaled Corticosteroids Therapy Among Patients with COPD: Systematic Review and Meta-analysis.绝对嗜酸性粒细胞计数指导慢性阻塞性肺疾病患者吸入糖皮质激素治疗：系统评价和荟萃分析
Curr Drug Targets. 2019;20(16):1670-1679. doi: 10.2174/1389450120666190808141625.
8
Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?吸入性糖皮质激素和大环内酯类药物疗法在支气管扩张症中起作用吗？
Drugs. 2007;67(7):965-74. doi: 10.2165/00003495-200767070-00002.
9
Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review.吸入性皮质类固醇在非囊性纤维化支气管扩张症成人患者中的应用：从基础到临床。一篇叙述性综述。
Drugs. 2022 Sep;82(14):1453-1468. doi: 10.1007/s40265-022-01785-1. Epub 2022 Oct 20.
10
Subjective benefit of inhaled therapies in patients with bronchiectasis: a questionnaire study.支气管扩张症患者吸入疗法的主观益处：一项问卷调查研究
Int J Clin Pract. 2004 May;58(5):441-3. doi: 10.1111/j.1368-5031.2004.00001.x.

引用本文的文献

1
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).吸入性糖皮质激素在支气管扩张症中的应用：来自欧洲支气管扩张症注册研究（EMBARC）的数据。
Thorax. 2025 May 20;80(6):358-368. doi: 10.1136/thorax-2024-221825.
2
Bronchiectasis.支气管扩张症
Open Respir Arch. 2024 May 29;6(3):100339. doi: 10.1016/j.opresp.2024.100339. eCollection 2024 Jul-Sep.
3
Bronchiectasis management in adults: state of the art and future directions.成人支气管扩张症的管理：现状和未来方向。
Eur Respir J. 2024 Jun 28;63(6). doi: 10.1183/13993003.00518-2024. Print 2024 Jun.
4
Endotypes of Paediatric Cough-Do They Exist and Finding New Techniques to Improve Clinical Outcomes.小儿咳嗽的内型——它们是否存在以及寻找改善临床结果的新技术
J Clin Med. 2024 Jan 28;13(3):756. doi: 10.3390/jcm13030756.
5
Simultaneous evaluation of the fractional exhaled nitric oxide and blood eosinophil count of T2-high endotype in patients with non-cystic fibrosis bronchiectasis.同时评估非囊性纤维化支气管扩张症患者 T2 高表型的呼出气一氧化氮分数和血嗜酸性粒细胞计数。
Chron Respir Dis. 2023 Jan-Dec;20:14799731231210559. doi: 10.1177/14799731231210559.
6
Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis.血嗜酸性粒细胞百分比可预测支气管扩张症患者对吸入性皮质类固醇的反应。
Clin Respir J. 2023 Jun;17(6):548-555. doi: 10.1111/crj.13624. Epub 2023 Apr 26.
7
Inhaled Corticosteroids and Bronchiectasis: Friend or Foe?吸入性糖皮质激素与支气管扩张症：是友还是敌？
J Clin Med. 2023 May 7;12(9):3322. doi: 10.3390/jcm12093322.
8
Exacerbation Prevention and Management of Bronchiectasis.支气管扩张症的急性加重预防与管理
Tuberc Respir Dis (Seoul). 2023 Jul;86(3):183-195. doi: 10.4046/trd.2023.0010. Epub 2023 May 10.
9
Insights into Personalised Medicine in Bronchiectasis.支气管扩张症个性化医疗的见解
J Pers Med. 2023 Jan 10;13(1):133. doi: 10.3390/jpm13010133.
10
Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review.吸入性皮质类固醇在非囊性纤维化支气管扩张症成人患者中的应用：从基础到临床。一篇叙述性综述。
Drugs. 2022 Sep;82(14):1453-1468. doi: 10.1007/s40265-022-01785-1. Epub 2022 Oct 20.